Transition Therapeutics (TTHI) Reports Q1 Loss of $0.12

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. BA
4. STX
5. NXPI
6. CSGP
7. LSTR
8. UPS
9. KIDS
10. V

Go back to Transition Therapeutics (TTHI) Reports Q1 Loss of $0.12

Transition Therapeutics Announces First Quarter Fiscal 2016 Financial Results

November 10, 2015 4:01 PM EST

TORONTO, Nov. 10, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical development company advancing novel therapeutics for CNS and metabolic disease indications, today announced its financial results for the three month period ended September 30, 2015. Investors are invited to participate in a conference call today at 4:30pm EST to discuss these results.   Dial in information for the call is as follows: (888) 227-6492 (North America) and (303) 223-2685 (International).  A live webcast can be accessed via Transition's website... More